Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v2-FR
Language French French
Date Updated 2017-11-06 2017-06-16
Drug Identification Number 02442035 02442035
Brand name CLONAZEPAM CLONAZEPAM
Common or Proper name CLONAZEPAM CLONAZEPAM
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients CLONAZEPAM CLONAZEPAM
Strength(s) 0.5MG 0.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N03AE N03AE
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-06-16 2017-06-16
Actual start date
Estimated end date 2017-06-26 2017-06-26
Actual end date 2017-07-23
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Alternate Sivem pack size available (500s)
Health Canada comments